Evidence map›Paper›PMID 9423885›Full record

ArticleInfection and immunity1998

Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice.

K A Kernacki, D J Goebel, M S Poosch, L D Hazlett

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2018
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Role of the Fas pathway in Pseudomonas aeruginosa keratitis.Investigative ophthalmology & visual science · 2010
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

K A KernackiDepartment of Anatomy/Cell Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
D J Goebel
M S Poosch
L D Hazlett
Wayne State University · US

Funding

VISION RESEARCH--COREP30EY004068 · NEI · WAYNE STATE UNIVERSITY · PI LINDA D HAZLETT · 1985 to 2026
$13.2M
ALTERATION WITH AGE OF RESISTANCE TO EYE INFECTIONSR01EY002986 · NEI · WAYNE STATE UNIVERSITY · PI HAZLETT, LINDA D · 1985 to 2013
$6.2M
NEI NIH HHS P30 EY004068NEI NIH HHS P30 EY04068NEI NIH HHS R01 EY002986NEI NIH HHS R01EY02986
6 · The paper itself

Abstract

Using a multiprobe RNase protection assay, we examined cytokine and chemokine mRNAs that were expressed after corneal infection with Pseudomonas aeruginosa in mice. Cytokines that were upregulated included interleukin-1alpha (IL-1alpha) and -1beta, IL-1 receptor antagonist, IL-6, IL-11, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, stem cell factor, lymphotoxin beta, transforming growth factor beta1, and tumor necrosis factor alpha. Chemokine transcripts that were upregulated included Eotaxin; gamma-interferon-inducible protein 10; monocyte chemoattractant protein 1; macrophage inflammatory proteins 1alpha, 1beta, and 2; and RANTES. Peak expression of these cytokines and chemokines was observed between 1 and 3 days after infection. These responses returned to or approached baseline preinfection levels by 7 days after ocular challenge. Identification of the various cytokines and chemokines upregulated during corneal infection provides important information relevant to unraveling the pathogenesis induced by this bacterium and provides hope that specific molecules can be targeted for therapy.

Indexed as

Chemokines, CCGene ExpressionAnimalsChemokine CCL11Chemokine CCL2Chemokine CCL4Chemokine CCL5Chemokine CXCL2ChemokinesCorneal DiseasesCytokinesGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorInterleukin-1Interleukin-11Interleukin 1 Receptor Antagonist ProteinCcl11 protein, mouseChemokine CCL11Chemokine CCL2Chemokine CCL4Chemokine CCL5Chemokine CXCL2ChemokinesChemokines, CCCytokinesGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorIl1rn protein, mouseInterleukin-1Interleukin-11Interleukin 1 Receptor Antagonist ProteinInterleukin-6Ltb protein, mouseLymphotoxin-alphaLymphotoxin-betaMacrophage Colony-Stimulating FactorMacrophage Inflammatory ProteinsMembrane ProteinsMonokinesRNA, MessengerSialoglycoproteinsStem Cell FactorTransforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID9423885
PMCPMC107909
OpenAlexW1840611749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.